Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Senicapoc in Sickle Cell Disease
NCT07282210Phase 2Recruiting
- Sponsor
- Biossil
- Start
- Nov 2026
- Primary completion
- Oct 2029
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of senicapoc in sickle cell disease (SCD), sponsored by Biossil. Started Nov 2026; status: recruiting.
02
Drugs
senicapoc
03
Conditions
sickle cell disease (SCD)
Beyond the preview
Go deeper on NCT07282210.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07282210.